Savara Inc.SVRANASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank38
5Y CAGR-55.0%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

5Y CAGR
-55.0%/yr
Long-term compound
Percentile
P38
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 20251.51%
Q3 2025-0.77%
Q2 20258.31%
Q1 2025-17.75%
Q4 202414.69%
Q3 202415.29%
Q2 20244.82%
Q1 202431.86%
Q4 2023-8.08%
Q3 202355.62%
Q2 20231.98%
Q1 202314.58%
Q4 2022-6.44%
Q3 202227.00%
Q2 202212.91%
Q1 2022-25.39%
Q4 202116.63%
Q3 2021-9.93%
Q2 2021-4.44%
Q1 2021-25.28%
Q4 202081.28%
Q3 2020-7.83%
Q2 2020-53.95%
Q1 202051.32%
Q4 2019-8.90%
Q3 2019-8.50%
Q2 20194.44%
Q1 20191.64%
Q4 20183.66%
Q3 20182.60%
Q2 20188.54%
Q1 201832.72%
Q4 201729.56%
Q3 201719.26%
Q2 2017188.57%
Q1 20171750.00%
Q4 2016-98.47%
Q3 2016-34.37%
Q2 2016-1.56%
Q1 201610.02%